This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Investigation of [6R] 5,10-methylenetetrahydrofola...
Clinical trial

Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Read time: 1 mins
Last updated:5th Nov 2013
An Open-Label, Multicenter, Phase I/II Clinical Trial to Identify the [6R] 5,10-methylenetetrahydrofolate Dose with Most Favorable Safety Prospect and Confirmed Ability to Mitigate High-Dose Methotrexate Induced Toxicity during Treatment of Osteosarcoma Patients
Category Value
Study start date 2013-11-05

View full details